Posted by DreamGladiator > 2020-08-29 09:52 | Report Abuse

ya kah

Posted by DreamGladiator > 2020-08-29 09:53 | Report Abuse

misti itu macam la

Posted by gemfinder > 2020-08-29 09:53 | Report Abuse

Glove wil sufer bigest drop when trump aprove vacine in oct

Posted by DreamGladiator > 2020-08-29 09:53 | Report Abuse

baru la ada tunjuk leadership by example

Posted by DreamGladiator > 2020-08-29 09:53 | Report Abuse

betul aah

Posted by supersinginvestor > 2020-08-29 09:54 | Report Abuse

greed made u sell gloves for pharmas now pharmas go down n gloves go up.. u will burn from the inside then u will.come to gloves and cause havoc n spread false info...
There is no worse pain for the greedy then see shares they sold go up...its eats u from inside...

Posted by gemfinder > 2020-08-29 09:54 | Report Abuse

When u stil asking betul ka, then it is too late to sell

Posted by DreamGladiator > 2020-08-29 09:56 | Report Abuse

when you're overpromoting so much then it's time to sell

Posted by DreamGladiator > 2020-08-29 09:57 | Report Abuse

when you're hard selling so much then it's too late to buy

Posted by supersinginvestor > 2020-08-29 10:08 | Report Abuse

Be honest if there is a vaccine the batches will come directly from producer.. it will be years before bottling will be allowed in another country...
Maybe 2025.. first the front line n orang besar will get it...then the rest which is a long way off..n they r still.exposed to covid...soo plz dont come to gloves n talk kok la... u ikan bilis knoe nothing about vaccine just stick to that.. be honest tell us why u like pharmas.. u like it cos can goreng la.. not cos of vaccine.. gloves mahal ikan bilis hard goreng syndicate oso hard goreng wor..

Posted by Ny036 > 2020-08-29 11:01 | Report Abuse

The whole world are desperate to get a vaccine. Earlier will be October/Nov.
Weather it 50% efficient , I think every country want it as they are desperate to improve their collapse economy. Some leader will do it in order to be power.
Malaysia is no exemption. Pharma and Dpharma will do for the goverment project and sponsor by the goverment budget. (Foc) . Whereas maybe solution or even Bintai and others will do for private which citizen have to pay for it.
For time being it is quite safe to invest n play this vaccine counter.

Posted by jiasyn > 2020-08-29 11:03 | Report Abuse

Whole world are waiting for vaccine. Else RMCO will extend forever. So we still hope for Vaccine la.

Posted by KenKen84 > 2020-08-29 12:42 | Report Abuse

additional ... whole world wants safe vaccines. rush & unsafe vaccines make thing worse

Posted by stockwinner > 2020-08-29 13:38 | Report Abuse

Buy on RUMOURS (Vaccine), SELL on News (Bonus Issue for Gloves - risk of heavy profit taking next week). You don't need a PhD to understand that.

Posted by stockraider > 2020-08-29 13:38 | Report Abuse

If u want play covid19 vaccine, solution with cansino is the best loh..!!

Do not waste time with sohai dpharma & pharmaniaga brady waste of time & bullshitting loh...!!

Then people say titijaya, hwgb, bintai all these bullshitting or takes alot of time to arrive in msia mah...!!

Stick with the brightest prospect Solution with cansino team up loh...nothing can beat their quality & efficiency loh..!!

Posted by stockraider > 2020-08-29 13:39 | Report Abuse

U only need a real vaccine like cansino with Solution their distributor mah....!!

Not just talk cock like Dpharma & pharmaniaga...say got covid19 vaccine but when ask what type of covid19 vaccine they got ??

Answer ; Tak tahu loh...!!

Stupid con job this dpharma & pharmaniaga loh...!!

Everything say govt...govt....everytime say khairi...khairi loh..!!

Bila tanya what covid19 vaccine ia ada...TAK TAHU LOH...!!


Brady bullshitters these people mah...!!

Posted by stockraider > 2020-08-29 13:39 | Report Abuse

Shiok sendiri loh...!!

Say prepare prepare...tapi takala vaccine pun loh...!!

Just a dream...n cakap kosong...not like solution very real mah..!!

Not just talk cock like Dpharma & pharmaniaga...say got covid19 vaccine but when ask what type of covid19 vaccine they got ??

Answer ; Tak tahu loh...!!

Stupid con job this dpharma & pharmaniaga loh...!!

Everything say govt...govt....everytime say khairi...khairi loh..!!

Bila tanya what covid19 vaccine ia ada...TAK TAHU LOH...!!


Brady bullshitters these people mah...!!

Posted by stockwinner > Aug 28, 2020 1:57 PM | Report Abuse

Ignorance of ignorance. Dharma and Pharmaniaga are prepared for vaccine project anytime, that's the only info we need. Not those circus shows like Mou or shook sendiri announcement.

Posted by emc2garylow > 2020-08-29 13:44 | Report Abuse

Market will stumble when sabah election pintu belakang lose.... Lose sabah hint that PN is not welcome by rakyat, after collapse umno baby again will be put into fridge

Posted by stockwinner > 2020-08-29 13:45 | Report Abuse

Vaccine = Viagra for the entire market, and poison to gloves counters. With 35 potential vaccine candidates under human trail now, we need only 1 success before year end.
As Pharma/Dpharma already have the existing capacity to produce, don't think it will take more than a few months to kick start the project

Posted by SEE_Research > 2020-08-29 14:26 | Report Abuse

Bursa Stock Talk

Monday, 25 March 2013
Caring Pharmacy Group Berhad & Pharmacy Industry in Malaysia
In 2012, there were 2,095 community pharmacies in Malaysia.



As at 31 December 2012, Caring has a total number of 76 community pharmacies operating under the name of 'CARiNG". For FYE 31 May 2012, Caring achieved revenue of RM248.28m, or on average RM3.27m/ pharmacy.

RM[x]m, representing approximately 41.15% of the gross proceeds will be utilised towards expansion of new community pharmacy outlets, setting up 25 to 30 new community pharmacies in Peninsula Malaysia.

Major suppliers (supplies more than 10% of total products offering)
Zuellig Pharma Sdn Bhd
DKSH Malaysia Sdn Bhd




Average revenue per type of outlet

Shopping complex: RM3.86m/outlet
Street outlet: RMRM2.89m/outlet
Specialised retail centre: RM2.35m/outlet












Capital and Set-up Costs
The barriers to entry into the community pharmacy industry are relatively low based on capital requirements (excluding land and building)

The capital requirements of setting-up an independent community pharmacy would be between RM200,000 to RM400,000 which includes both renovation costs (

Posted by SEE_Research > 2020-08-29 14:29 | Report Abuse

TRENDING
Pharmaniaga ready to back govt in Covid-19 vaccine supply
GROOVE
'Black Panther' star Chadwick Boseman dies from colon cancer
Pharmaniaga ready to back govt in Covid-19 vaccine supply
WORLD
Riot in Sweden amidst Quran-burning rally
Pharmaniaga ready to back govt in Covid-19 vaccine supply
NATION
Ally Mukhriz 'deeply ashamed' for breaking RMCO rules
Pharmaniaga ready to back govt in Covid-19 vaccine supply
NATION
RMCO extended until Dec 31, says PM Muhyiddin
Pharmaniaga ready to back govt in Covid-19 vaccine supply
NATION
Poor Sabah farmer wins RM19.88 million Sports Toto jackpot


BUSINESS
Pharmaniaga ready to back govt in Covid-19 vaccine supply
Ayisy Yusof
By Ayisy Yusof
August 24, 2020 @ 6:48pm

Pharmaniaga ready to back govt in Covid-19 vaccine supply
Pharmaniaga acting managing director Mohamed Iqbal Abdul Rahman said the G2G arrangements would be vital for Malaysia to procure the vaccine but currently the details had yet to be ironed out.
KUALA LUMPUR: Pharmaniaga Bhd is ready to support the government in supplying Covid-19 vaccine locally, which is expected to be commercially available as early as the first quarter (Q1) of 2021

However, the supply will be heavily dependent on the government-to-government (G2G) arrangements in procuring the vaccine from the potential producing countries (China and India).


Market observers said the Covid-19 vaccine was slated to be readily available by end of this year.

The vaccine was reportedly in various clinical trials in high-case countries such as China, India, the United States and Russia.

Pharmaniaga acting managing director Mohamed Iqbal Abdul Rahman said the G2G arrangements would be vital for Malaysia to procure the vaccine but currently the details had yet to be ironed out.

"We have the existing capability and infrastructure to repurpose our vaccine plant to facilitate the 'fill and finish' for the vaccine if the government secures the procurement from producers," he said at Pharmaniaga's second quarter result briefing today.

Mohamed Iqbal said Pharmaniaga was ready in terms of logistics and distribution.

"We will allocate about RM2 million investment to repurpose our existing small volume injectable plant. This is to cater for the Covid-19 fill and finish for the inactivated/killed vaccine.

Posted by SEE_Research > 2020-08-29 14:47 | Report Abuse

Mr Mohamed Iqbal/Acting Managing Director of Pharmaniaga will allocate about RM 2 million investment in our small volume injectable plant,
Is this investment, whether serious or a small joke to start with such a small sum,
RM 2 million, perhaps can only start 3 or 4 pharmacy outlets in Kuala Lumpur
(as one average outlet in Kuala Lumpur is about
RM 500,000.00, Pls note on the above report on start up of 1 pharmacy outlet)

Pls check out from the real giant of pharmaceutical establishments in the world, example
A. Bristol Myers Squibb
B. Novartis
C. Pfizer
D. Novartis
E. Sanofi

It is very capital intensive,
With such a paltry sum RM 2 millions equal to the USD 476,000.00
You can visual whether the
Principal inventor. at the origin country will select such a company as their refill of the Covid vaccine.

Posted by Ny036 > 2020-08-29 15:22 | Report Abuse

Is this 2 mil is additional to the existing facility. An add value ?

Posted by SEE_Research > 2020-08-29 15:55 | Report Abuse

When the Malaysian interested companies approach the
Principal vaccine originator ,
in their initial discussion, when ask to state their keeness to participate in the refilling, repacking, storage and final deliveries,
HOW MUCH WILL BE YOUR INITIAL CAPITAL INVESTMENTS, WHEN OUR REPLY IS AROUND
USD 476,000.00,
THE CEO OF THE SAID INVENTOR OF THE VACCINE WILL STAND UP AND SHOW THAT IS THE DOOR IN AND THE DOOR OUT,

PERHAPS, NOT HE MAY IN HIS SITTING POSITION, NOT SO GRACIOUS,
WITH HAND POINTING TO THE OUT/
DOOR SIGNAGE.


====================================
REMARKS

THE REPACKING, REFILLING PROCESSES ARE I NOT,
IS NOT THAT SIMPLE,
LIKE REFILLING BOTTLED DRINKS,
PLASTICS BOTTLES POUR INTO,
IT IS CAPITAL INTENSIVE PROCESSES WITH VALUED ADD,
COMPLETE
IN THE TOTAL LOGISTICS WITH THE OPTIMUM COLD ROOM TEMPERATURE FACILITIES

Posted by SEE_Research > 2020-08-29 16:11 | Report Abuse

This chapter provides best practice guidance for storage
and handling. Additional resources are available in
Appendix C.
Vaccine Storage and Handling
There are few immunization issues more important than
the appropriate storage and handling of vaccines. The
success of efforts against vaccine-preventable diseases
is attributable in part to proper storage and handling of
vaccines. Vaccines exposed to temperatures outside the
recommended ranges can have reduced potency and
protection. Storage and handling errors can cost thousands
of dollars in wasted vaccine and revaccination. Errors can
also result in the loss of patient confidence when repeat
doses are required. It is better to not vaccinate than to
administer a dose of vaccine that has been mishandled.
Vaccine management, including proper storage and
handling procedures, is the basis on which good immuniza
-
tion practices are built.
Vaccines must be stored properly from the time they
are manufactured until they are administered. Proper
maintenance of vaccines during transport is known as the
cold chain. A proper cold chain is a temperature-controlled
supply chain that includes all equipment and procedures
used in the transport and storage and handling of vaccines
from the time of manufacturer to administration of the
vaccine. By following a few simple steps and implementing
best storage and handling practices, providers can ensure
that patients will get the full benefit of vaccines they
receive.
Vaccine Storage Temperatures
Vaccines are fragile. They must be maintained at the
temperatures recommended by vaccine manufacturers
and protected from light at every link in the cold chain.
Most live virus vaccines tolerate freezing temperatures, but
deteriorate rapidly after they are removed from storage.
Inactivated vaccines can be damaged by exposure to
temperature fluctuations (e.g., extreme heat or freezing
temperatures). Potency can be adversely affected if
vaccines are left out too long or exposed to multiple
temperature excursions (out-of-range temperatures) that
can have a cumulative negative effect. It is a good idea to
post a sign on the front of the storage unit(s) indicating
which vaccines should be stored in the freezer and which
should be stored in the refrigerator.
Freezer
All varicella-containing vaccines should be stored in a
continuously frozen state at the manufacturer recommendations

Posted by SEE_Research > 2020-08-29 16:34 | Report Abuse

Mr Mohamed Iqbal, Acting Managing Director,
Pharmaniaga, Puchong
Stated
"We will allocate about RM2 million investment to repurpose our existing small volume injectable plant. This is to cater for the Covid-19 fill and finish for the inactivated/killed vaccine

Small volume injectable plant,
If you are the CEO of the original inventor,
Covid 19 vaccine,

Leave for you to answer
WHAT WILL BE YOUR RESPONSE?

Posted by sengkee > 2020-08-29 16:53 | Report Abuse

Can LTAT only offer to privatise it based on its NTA of RM1.37 only?

Posted by stockwinner > 2020-08-29 17:01 | Report Abuse

What's the problem with spending small money on what I've already owned?

Spend RM2 million to repurpose existing plant sounds like

"I Spend RM20k to renovate my bungalow's maid toilet. my bungalow is worth 5.5 million with 6 toilets." Or

"I spend RM3k for one tyre of my Ferrari F8 Tributo"

Posted by KenKen84 > 2020-08-29 17:23 | Report Abuse

quiet la . stupid spammer

Posted by stockwinner > 2020-08-29 17:32 | Report Abuse

@SEE_Reseach No body judge a potential partners by looking solely on a single business decision they made. Unless you are a Pasar Malam CEO.
You have to take into consideration of their profile or background e.g. track records, human capital, distribution network, production capacity, reputations, technologies, relationships etc etc - both dpharma and pharmaniaga have it.

Why most people buy Toyota and Honda? think of it.

Posted by BigBladd > 2020-08-29 19:00 | Report Abuse

...and their BOD

Posted by Ny036 > 2020-08-29 19:43 | Report Abuse

Tis vaccine award will be goverment decision.
Kj initial mention Dpharma and Pharma to take the job but due to politic of open tender system , he has mention open.
Who else the goverment will award if not glc. ?
Anyone can predict? Kpj, apex health or .......
Tis is world problem vaccine can let inexperience company to do the job. Who want to responsible. Worse is buy ready made and appoint a company as orang tengah.

Posted by SEE_Research > 2020-08-29 19:51 | Report Abuse

Their Board of Directors, very questionable as there are continuous court cases in,
and out among themselves.

Posted by SEE_Research > 2020-08-29 19:55 | Report Abuse

https://www.theedgemarkets.com/article/boustead-confirms-%C2%A364m-suit-against-former-board-members-writ-not-yet-served

Posted by stockwinner > 2020-08-29 21:08 | Report Abuse

@SEE_Research. The "former" board member la, dear researcher. Why you spreading fake news on current BOD?

Posted by EatThis > 2020-08-29 21:17 | Report Abuse

Too many "if" and challenges await. Risky counter. May boil down to nothing eventually.

Posted by Yu_and_Mee > 2020-08-29 21:33 | Report Abuse

wow, lengthy sharing from @SEE_Research.
good, please share lengthy lengthy messages. Please continue to spam pharma and dpharma rooms.

Posted by Yu_and_Mee > 2020-08-29 21:33 | Report Abuse

KUALA LUMPUR (Aug 11): Boustead Holdings Bhd confirmed that it has filed a suit at the High Court against its former managing director Tan Sri Che Lodin Wok Kamaruddin and five former directors, seeking £6.4 million (RM35.37 million).

However, the diversified conglomerate, which is controlled by Lembaga Tabung Angkatan Tentera with a 59.42% stake, pointed out that the writ is yet to be served.

"The writ is yet to be served," it said. "Announcement on the development of the above matter will be made in due course."

Boustead also confirmed that the claim is "up to £6.4 million or other sum deemed fit by the court, for breaching their fiduciary obligations as directors under the Companies Act 1965".

Referring to an article by theedgemarkets.com, Boustead said the writ "has indeed been filed on June 29, 2020" against the six individuals.

Apart from Lodin, others are former chairman Tan Sri Mohd Ghazali Che Mat, as well as former directors Datuk Azzat Kamaludin, Datuk Francis Tan Leh Kiah, Datuk Seri Ghazali Mohd Ali and Datuk Wira Dr Megat Abdul Rahman Megat Ahmad.

Lodin resigned in November 2018, while Mohd Ghazali retired as Boustead chairman in July last year. The other four directors, too, left the group last year.

Boustead had been subject to criticism due to high debt strain from its expansion exercises.

It resulted in a total borrowing of RM7.9 billion against shareholders' equity of RM3.74 billion at end of last year.

Amid high debt and shrinking cash flow as its businesses underperformed, Boustead was in the red in the financial year ended Dec 31, 2018 (FY18) and in FY19, when it opted for a RM1.15 billion kitchen-sinking to tidy its books.

It is currently said to be undertaking a debt restructuring of RM5.4 billion plus the rationalisation of non-core assets to improve cash flow.

Posted by Yu_and_Mee > 2020-08-29 21:34 | Report Abuse

can get enough fridge?


This chapter provides best practice guidance for storage
and handling. Additional resources are available in
Appendix C.
Vaccine Storage and Handling
There are few immunization issues more important than
the appropriate storage and handling of vaccines. The
success of efforts against vaccine-preventable diseases
is attributable in part to proper storage and handling of
vaccines. Vaccines exposed to temperatures outside the
recommended ranges can have reduced potency and
protection. Storage and handling errors can cost thousands
of dollars in wasted vaccine and revaccination. Errors can
also result in the loss of patient confidence when repeat
doses are required. It is better to not vaccinate than to
administer a dose of vaccine that has been mishandled.
Vaccine management, including proper storage and
handling procedures, is the basis on which good immuniza
-
tion practices are built.
Vaccines must be stored properly from the time they
are manufactured until they are administered. Proper
maintenance of vaccines during transport is known as the
cold chain. A proper cold chain is a temperature-controlled
supply chain that includes all equipment and procedures
used in the transport and storage and handling of vaccines
from the time of manufacturer to administration of the
vaccine. By following a few simple steps and implementing
best storage and handling practices, providers can ensure
that patients will get the full benefit of vaccines they
receive.
Vaccine Storage Temperatures
Vaccines are fragile. They must be maintained at the
temperatures recommended by vaccine manufacturers
and protected from light at every link in the cold chain.
Most live virus vaccines tolerate freezing temperatures, but
deteriorate rapidly after they are removed from storage.
Inactivated vaccines can be damaged by exposure to
temperature fluctuations (e.g., extreme heat or freezing
temperatures). Potency can be adversely affected if
vaccines are left out too long or exposed to multiple
temperature excursions (out-of-range temperatures) that
can have a cumulative negative effect. It is a good idea to
post a sign on the front of the storage unit(s) indicating
which vaccines should be stored in the freezer and which
should be stored in the refrigerator.

Posted by Yu_and_Mee > 2020-08-29 21:34 | Report Abuse

@SE_Research, what does this message means?

When the Malaysian interested companies approach the
Principal vaccine originator ,
in their initial discussion, when ask to state their keeness to participate in the refilling, repacking, storage and final deliveries,
HOW MUCH WILL BE YOUR INITIAL CAPITAL INVESTMENTS, WHEN OUR REPLY IS AROUND
USD 476,000.00,
THE CEO OF THE SAID INVENTOR OF THE VACCINE WILL STAND UP AND SHOW THAT IS THE DOOR IN AND THE DOOR OUT,

PERHAPS, NOT HE MAY IN HIS SITTING POSITION, NOT SO GRACIOUS,
WITH HAND POINTING TO THE OUT/
DOOR SIGNAGE.


====================================
REMARKS

THE REPACKING, REFILLING PROCESSES ARE I NOT,
IS NOT THAT SIMPLE,
LIKE REFILLING BOTTLED DRINKS,
PLASTICS BOTTLES POUR INTO,
IT IS CAPITAL INTENSIVE PROCESSES WITH VALUED ADD,
COMPLETE
IN THE TOTAL LOGISTICS WITH THE OPTIMUM COLD ROOM TEMPERATURE FACILITIES

Posted by Yu_and_Mee > 2020-08-29 21:35 | Report Abuse

@SE_Research, does it means pharma just spend 2 millions for this business and plan to make 2 billions revenue or profit?

Pharmaniaga ready to back govt in Covid-19 vaccine supply
GROOVE
'Black Panther' star Chadwick Boseman dies from colon cancer
Pharmaniaga ready to back govt in Covid-19 vaccine supply
WORLD
Riot in Sweden amidst Quran-burning rally
Pharmaniaga ready to back govt in Covid-19 vaccine supply
NATION
Ally Mukhriz 'deeply ashamed' for breaking RMCO rules
Pharmaniaga ready to back govt in Covid-19 vaccine supply
NATION
RMCO extended until Dec 31, says PM Muhyiddin
Pharmaniaga ready to back govt in Covid-19 vaccine supply
NATION
Poor Sabah farmer wins RM19.88 million Sports Toto jackpot


BUSINESS
Pharmaniaga ready to back govt in Covid-19 vaccine supply
Ayisy Yusof
By Ayisy Yusof
August 24, 2020 @ 6:48pm

Pharmaniaga ready to back govt in Covid-19 vaccine supply
Pharmaniaga acting managing director Mohamed Iqbal Abdul Rahman said the G2G arrangements would be vital for Malaysia to procure the vaccine but currently the details had yet to be ironed out.
KUALA LUMPUR: Pharmaniaga Bhd is ready to support the government in supplying Covid-19 vaccine locally, which is expected to be commercially available as early as the first quarter (Q1) of 2021

However, the supply will be heavily dependent on the government-to-government (G2G) arrangements in procuring the vaccine from the potential producing countries (China and India).


Market observers said the Covid-19 vaccine was slated to be readily available by end of this year.

The vaccine was reportedly in various clinical trials in high-case countries such as China, India, the United States and Russia.

Pharmaniaga acting managing director Mohamed Iqbal Abdul Rahman said the G2G arrangements would be vital for Malaysia to procure the vaccine but currently the details had yet to be ironed out.

"We have the existing capability and infrastructure to repurpose our vaccine plant to facilitate the 'fill and finish' for the vaccine if the government secures the procurement from producers," he said at Pharmaniaga's second quarter result briefing today.

Mohamed Iqbal said Pharmaniaga was ready in terms of logistics and distribution.

"We will allocate about RM2 million investment to repurpose our existing small volume injectable plant. This is to cater for the Covid-19 fill and finish for the inactivated/killed vaccine.

Posted by Yu_and_Mee > 2020-08-29 21:36 | Report Abuse

If 2m to get 2b revenue or profit, then this is really a great business to go for.
But why only pharma?

Posted by Yu_and_Mee > 2020-08-29 21:37 | Report Abuse

IJM should also invest 2m, then can go back to MSCI

Posted by Yu_and_Mee > 2020-08-29 21:37 | Report Abuse

Caring pharmacy also can invest 2m for the business right?

Monday, 25 March 2013
Caring Pharmacy Group Berhad & Pharmacy Industry in Malaysia
In 2012, there were 2,095 community pharmacies in Malaysia.



As at 31 December 2012, Caring has a total number of 76 community pharmacies operating under the name of 'CARiNG". For FYE 31 May 2012, Caring achieved revenue of RM248.28m, or on average RM3.27m/ pharmacy.

RM[x]m, representing approximately 41.15% of the gross proceeds will be utilised towards expansion of new community pharmacy outlets, setting up 25 to 30 new community pharmacies in Peninsula Malaysia.

Major suppliers (supplies more than 10% of total products offering)
Zuellig Pharma Sdn Bhd
DKSH Malaysia Sdn Bhd




Average revenue per type of outlet

Shopping complex: RM3.86m/outlet
Street outlet: RMRM2.89m/outlet
Specialised retail centre: RM2.35m/outlet












Capital and Set-up Costs
The barriers to entry into the community pharmacy industry are relatively low based on capital requirements (excluding land and building)

The capital requirements of setting-up an independent community pharmacy would be between RM200,000 to RM400,000 which includes both renovation costs (

Posted by Yu_and_Mee > 2020-08-29 21:38 | Report Abuse

So awesome profit, i also want to buy pharma.
but why not kyy invest 2m instead?

Posted by Yu_and_Mee > 2020-08-29 21:39 | Report Abuse

Solution should invest 2m and work with vaccine companies, then Solution can be another pharma

Posted by Yu_and_Mee > 2020-08-29 21:39 | Report Abuse

KUALA LUMPUR (Aug 25): theedgemarkets.com highlighted 11 stocks at Bursa Malaysia’s afternoon close today. One stock displayed positive momentum while 10 showed negative momentum.

The stock with positive momentum was:

M3 Technologies Asia Bhd — up 1.5 sen at 16.5 sen

Sponsored Content

Stocks with negative momentum were:

B.I.G. Industries Bhd — up four sen at 57 sen

Bintai Kinden Corp Bhd — up 25.5 sen at 66 sen

Duopharma Biotech Bhd — up 71 sen at RM4.09

Grand-Flo Bhd — up 3.5 sen at 31 sen

Ho Wah Genting Bhd — up 12 sen at RM1.23

LebTech Bhd — up one sen at RM1.22

Pharmaniaga Bhd — up RM1.11 at RM6.38

Rev Asia Bhd — up 3.5 sen at 29 sen

Solution Group Bhd — up 18 sen at 81 sen

WMG Holdings Bhd — up 2.5 sen at 16 sen

The list of stocks with momentum is generated using a proprietary mathematical algorithm highlighting stocks with a build-up in trading volume and price. The algorithm differentiates between stocks that exhibit positive (+ve) momentum and negative (-ve) momentum.

This list is not a buy or sell recommendation. It merely tells you which stocks are seeing higher than normal volume and price movements.

The share price may move up or down from this point. But the “+ve” (suggesting a rising price trend on volume) and “-ve” (suggesting a falling price trend on volume) indicators should give readers a better idea of what the market is buying and when to sell. Note also that momentum generally only persists for a short period of time.

However, each stock has an accompanying fundamental score and valuation score to help readers evaluate the attractiveness of the stocks, if they want to ride the momentum.

Edited by Lam Jian Wyn

Posted by SEE_Research > 2020-08-29 21:40 | Report Abuse

Boustead

Pls read carefully, this is current report by the
Edge Markets,
Reporting time :20:28,
11August 2020

On the current situation by Boustead, Malaysia on the
Court actions on totally
5 previous Board of Directors (including the previous MD) for
BREACHING THEIR FIDUCIARY OBLIGATIONS AS DIRECTORS UNDER COMPANIES ACT 1965
SUM INVOLVED RM 35.37 millions


=======================================
Remarks
(i) sum involved is RM 35.37millions and not small amount
(ii) AND NOT OLD REPORT thru WhatsApp, etc
(iii) To be honest, some of my close investors have interest to invest in the pharmaceutical stocks, and upon ongoing researches manage to find the skeletons in the closet.

Sincerely,

When some of the investors in this forum requested for further information,
the necessary replies as per their request.
Likely, when the management of some rubber gloves stocks run into some
BAD malpractices,
the necessary reports will be issued, too.

Posted by Yu_and_Mee > 2020-08-29 21:40 | Report Abuse

Good news! Please read!

（吉隆坡24日讯）发马（PHARMA,7081,主板医疗保健组）只需投资200万令吉便可运用现有设施进行冠病疫苗灌封，每月将可灌封1000万剂量的疫苗。

代董事经理莫哈末依克巴指出，集团已向全国科学理事会提呈计划、产能与能力详情。

“一旦有疫苗，便可开始灌封，以解决国内对冠病疫苗的紧急需求。目前挑战是全球抢订疫苗，对发马而言有了疫苗便可即时灌封。”

科学、工艺与革新部长凯里上月指出，政府同意让发马与联合药业（DPHARMA,7148,主板医疗保健组）成为疫苗灌封中心。

莫哈末依克巴指出，该家国内最大药业公司，将于2022年完成设立清真疫苗中心。

该家政府相关公司制定6大策略带领公司至另一层次，将持续提供最高水平服务，让卫生部履行保健义务，发马则是最佳物流伙伴。

“虽然获取分销与物流订单至2024年，但我们也期许良好纪录、原有基建、整合资讯工艺，最重要的是经验丰富人力资源，可获考量延长有关订单。”

他说，这些年来发马已开展数码措施，确保行管期间受干扰程度减至最低。公司将扩大产品组合，新产品由内部生产，将强化代理与经销渠道和扩展一站中心等。

“发马有300策略伙伴，超过6000家私人医院、全科医生、药剂行等，同时将进一步加强消费者忠诚度。”

发马继续给予现有员工所需培训，遵守法规与法定需求。

目前该公司聘3500员工，这是其最重要资产，其中国内员工占99.5%，国际人才多在研发部。

他表示，发马已采纳新常态营运方式，除居家工作和线上会议，体现更大效益。

截至今年6月30日上半年，净利从前期2889万令吉增长至3238万令吉，营收从13亿9000万增加至14亿7000万令吉。

次季印尼业务仍然蒙亏200万令吉，主要是高融资成本和政府医院延迟付款；正采取措施客服此问题。预期万隆生产设施扩展销售渠道，2021年有望盈亏持平，印尼业务长远有望转亏为盈。



https://www.sinchew.com.my/content/content_2331320.html

Posted by pang72 > 2020-08-29 21:41 | Report Abuse

Pharma easily over Rm6 next week